Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Psychiatric Services (Washington, D.C.)|May 2, 2001
The EEOC charge priority policy and claimants with psychiatric disabilitiesM D Ullman, M C Johnsen, K Moss, et al.Journal of Lipid Research|October 1, 1991
Rapid isolation of monosialogangliosides from bovine brain gangliosides by selective-overload chromatographyO Koul, M Prada-Maluf, R H McCluer, et al.Neurology|October 1, 1982
Fabry disease: detection of heterozygotes by examination of glycolipids in urinary sedimentW J Cable, R H McCluer, E H Kolodny, et al.Brain Research. Molecular Brain Research|October 16, 1999
PC12 cells transfected with a C-terminal fragment of the amyloid precursor protein (APP C-100), exhibit enhanced sensitivity to the calcium ionophore A23187, and diminished sensitivity to hydrogen peroxideC McKeon-O'Malley, J Wells, R Fine, et al.Annals of Neurology|May 1, 1988
Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlationE M Kaye, E H Kolodny, E L Logigian, et al.Annals of Neurology|August 1, 1986
Type 2 and type 3 Gaucher disease: a morphological and biochemical studyE M Kaye, M D Ullman, E R Wilson, et al.Analytical Biochemistry|January 1, 1991
A high performance liquid chromatography method for the analysis of glycosphingolipids using galactose oxidase/NaB3H4 labeling of intact cells and synaptosomesR L Myers, M D Ullman, R F Ventura, et al.Archives of Neurology|April 1, 1989
Brain gangliosides in dementia of the Alzheimer typeP B Crino, M D Ullman, B A Vogt, et al.Neurology|December 1, 1992
Possible use of CSF glycosphingolipids for the diagnosis and therapeutic monitoring of lysosomal storage diseasesE M Kaye, M D Ullman, E H Kolodny, et al.American Journal of Medical Genetics|January 1, 1980
Plasma exchange removes glycosphingolipid in Fabry diseaseR E Pyeritz, M D Ullman, A B Moser, et al.Pageof 4